TAKE A LOOK AT WHICH REPORT YOUR PORTFOLIO'S BEEN MISSING...

Shareholders Foundation offers real-time reporting of class action exposure on a per transaction basis,
including the documents you will need for claim filing and settlement recovery.
Start Monitoring Your Investments

Vistagen Therapeutics Inc (NASDAQ:VTGN) Investor Investigation

  • If you purchased shares of Vistagen Therapeutics Inc (NASDAQ:VTGN), you have certain options and you should contact the Shareholders Foundation, Inc.

  • To have your information reviewed for options and to receive notifications about this investigation, please send an email to mail@shareholdersfoundation.com, or call us at (858) 779-1554.

Investigation Overview

Company
Vistagen Therapeutics Inc
Security
NASDAQ: VTGN

Summary

An investigation on behalf of investors in shares of Vistagen Therapeutics Inc (NASDAQ:VTGN) was announced over potential breaches of fiduciary duties by certain officers and directors at Vistagen Therapeutics.

The investigation by a law firm concerns whether certain Vistagen Therapeutics Inc (NASDAQ:VTGN officers and directors breached their fiduciary duties and caused damage to the company and its shareholders.

San Franciscom, CA based VistaGen Therapeutics, Inc. is a clinical-stage biopharmaceutical company. Shares of Vistagen Therapeutics Inc (NASDAQ:VTGN) declined from $16.00 per share in June 2015 to as low as $1.53 per share on September 26, 2017.

Start Monitoring Your Investments